These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15312518)

  • 1. [Morphology of portal hypertension at the early stage of liver damage induced by CCl4: an experimental study with dogs].
    Zhang RP; Zhang WH; Xue DB; Wei YW
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1118-21. PubMed ID: 15312518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of hepatic sinusoid capillarization during the formation of portal hypertension in fibrotic rats induced by dimethylnitrosamine].
    Lu X; Liu P; Xu GF; Liu CH; Li FH; Liu C
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):595-8. PubMed ID: 14572335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cordyceps mycelia extract decreases portal hypertension in rats with dimethylnitrosamine-induced liver cirrhosis: a study on its histological basis].
    Wang XB; Liu P; Tang ZP; Li FH; Liu CH; Hu YY; Xu LM
    Zhong Xi Yi Jie He Xue Bao; 2008 Nov; 6(11):1136-44. PubMed ID: 18990339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.
    Tu CT; Guo JS; Wang M; Wang JY
    J Gastroenterol Hepatol; 2007 Jun; 22(6):877-84. PubMed ID: 17565644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced ultrasound for quantitative assessment of portal pressure in canine liver fibrosis.
    Zhai L; Qiu LY; Zu Y; Yan Y; Ren XZ; Zhao JF; Liu YJ; Liu JB; Qian LX
    World J Gastroenterol; 2015 Apr; 21(15):4509-16. PubMed ID: 25914459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats.
    Gandhi CR; Nemoto EM; Watkins SC; Subbotin VM
    Liver; 1998 Feb; 18(1):39-48. PubMed ID: 9548266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
    Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel model of CCl4-induced cirrhosis with ascites in the mouse.
    Domenicali M; Caraceni P; Giannone F; Baldassarre M; Lucchetti G; Quarta C; Patti C; Catani L; Nanni C; Lemoli RM; Bernardi M
    J Hepatol; 2009 Dec; 51(6):991-9. PubMed ID: 19853952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.
    Theodorakis NG; Wang YN; Wu JM; Maluccio MA; Sitzmann JV; Skill NJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G792-9. PubMed ID: 19628654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats].
    Wang CP; Han J; Ma XM; Dong K; Xiang Y; Su SH; Feng YY; Yang YP
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3337-41. PubMed ID: 16409839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary experimental study on treatment of portal hypertension with auxiliary partial orthotopic liver transplantation].
    Shi LB; Peng CH; Peng SY; Liu YB; He W; Xu B; Chen XP; Bai MD; Wang Y; Tang Z
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):730-3. PubMed ID: 15585146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation.
    Geerts AM; Vanheule E; Praet M; Van Vlierberghe H; De Vos M; Colle I
    Int J Exp Pathol; 2008 Aug; 89(4):251-63. PubMed ID: 18715470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
    Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
    J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin ameliorates intrahepatic angiogenesis and capillarization of the sinusoids in carbon tetrachloride-induced rat liver fibrosis.
    Yao Q; Lin Y; Li X; Shen X; Wang J; Tu C
    Toxicol Lett; 2013 Sep; 222(1):72-82. PubMed ID: 23845850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of lifestyle interventions targeting physical exercise and caloric intake on cirrhosis regression in rats.
    Lafoz E; Campreciós G; García-Calderó H; Anton A; Vilaseca M; Ruart M; Guasch E; Garrabou G; Delgado TC; Martínez-Chantar ML; García-Martínez R; Gracia-Sancho J; Hernández-Gea V; García-Pagán JC
    Am J Physiol Gastrointest Liver Physiol; 2021 Dec; 321(6):G603-G616. PubMed ID: 34585619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A canine portal hypertension model induced by intra-portal administration of Sephadex microsphere.
    Jin W; Deng L; Zhang Q; Lin D; Zhu J; Chen Y; Chen B; Li J
    J Gastroenterol Hepatol; 2010 Apr; 25(4):778-85. PubMed ID: 20492334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
    Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
    J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of liver circulation and the outflow of bile and lymph in acute carbon tetrachloride poisoning].
    Koval'skaia KS; Gorin AS
    Farmakol Toksikol; 1976; 39(4):458-62. PubMed ID: 1027571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin decreases carbon tetrachloride-induced hepatic fibrosis by inhibiting transforming growth factor-beta.
    Park SY; Lee JY; Tak WY; Kweon YO; Lee MS
    Chin Med J (Engl); 2012 Sep; 125(17):3098-103. PubMed ID: 22932188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous treatment of portal hypertension and hepatic cirrhosis by splenohepatoplasty.
    Vara-Thorbeck R; Maza-Inza J
    Surg Gynecol Obstet; 1978 Sep; 147(3):391-6. PubMed ID: 684592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.